医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Successful Demonstration of STERRAD™ (Sterilization Equipment) to Run Using Electric Vehicles as Power Source – ASP Japan G.K.

2023年09月21日 AM09:00
このエントリーをはてなブックマークに追加


 

HAMAMATSU, Japan

In August 2023, Hamamatsu University Hospital, Hamamatsu Nissan Motor Co., Ltd. and ASP Japan, G.K. jointly conducted a demonstration experiment to operate STERRAD™ (sterilization equipment) using electric power from EVs (electric vehicles) at Hamamatsu University Hospital.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230918065946/en/

A demonstration experiment using electric vehicles (EVs) to operate sterilization equipment. (Photo: Business Wire)

A demonstration experiment using electric vehicles (EVs) to operate sterilization equipment. (Photo: Business Wire)

In the event of a disaster where lifelines are cut off, the STERRAD™ can be operated using only electricity, without water or gas, and can immediately begin sterilization operations as soon as power is available. The demonstration tests confirmed that STERRAD™ can operate normally on EV power, and is expected to further contribute to the recovery of the medical system in the event of a disaster or power outage.

https://www.asp.co.jp/activities/electric-vehicle-power

At ASP Japan G.K., our customers’ success inspires our innovation.

About ASP Japan, G.K.

As a leading company in the fields of cleaning and disinfection and sterilization, ASP Japan, G.K., continues to create an environment that provides safe and secure medical care through innovative products and services.

“To protect patients at their most critical moments” – all ASP employees involved in this mission never stop moving forward and always challenge the status quo to solve our customers’ problems.

ASP has a history of innovation in the fields of low-temperature sterilization and high-level disinfection. We developed the world’s first hydrogen peroxide gas plasma sterilization system, STERRAD™, a low-temperature sterilizer with improved safety and shorter sterilization time, which is earthquake-proof because it operates only on electricity. As a market leader in the low-temperature sterilizer market, we provide innovative products and services.

In the field of high-level disinfection, we have developed DisOPA™, which offers improved safety, shorter disinfection time, and ease of use. As a brand leader in the field of high-level disinfection, together with the Endoclens™ soft endoscope cleaning and disinfection device, DisOPA™ contributes to improving the quality and efficiency of soft endoscope reprocessing.

Product Name: STERRAD™ 100NX
Product Name: STERRAD NX™
Product Name: STERRAD™100S
Product Name: ENDOCLENS™ Neo
Product Name: ENDOCLENS™ -S
Product Name: ENDOCLENS™ -D
Product Name: DisOPA™ Solution 0.55%

View source version on businesswire.com: https://www.businesswire.com/news/home/20230918065946/en/

CONTACT

Please contact

ASP Japan G.K., Head Office +813-6712-1011

同じカテゴリーの記事 

  • Armis发布Armis Centrix™平台的第四季度更新
  • ケンビュー、来月6日の「モルガン・スタンレー世界消費者・小売会議」に参加へ
  • MGMA和Laserfiche研究发现,医疗保健行业领导者将自动化、消除员工倦怠视为技术集成的主要推动因素
  • MGMAとLaserficheが調査、ヘルスケアリーダーがテクノロジー統合の最優先課題として自動化と労働者の燃え尽き症候群を指摘
  • Vedanta Biosciences’ Key Microbiome Patents Fully Upheld in Three European Opposition Proceedings